MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Splanchnic Venous Thrombosis: Challenges and Opportunities
The status of management choices for this uncommon disease state.
By Mehran Midia, MD, FRCP(C), and Mahmood K. Razavi, MD, FSIR
Venous Rising
By Mahmood Razavi, MD
The NEPHRIC Trial
This prospective, randomized trial demonstrates the superiority of iodixanol to low-osmolar contrast media in preventing contrast-induced nephropathy.
By Adam Brodsky, MD, and Charles J. Davidson, MD
PLC's US Pivotal Study of RenalGuard Approved
October 14, 2011—PLC Medical Systems, Inc. (Milford, MA) announced that it has received final approval from the US Food and Drug Administration to commence its United States pivotal trial to study the efficacy of the company's RenalGuard therapy and RenalGuard system for the prevention of contrast-induced nephropathy.
